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Introduction 
Background 
Antibodies are used in the western blot technique to identify or quantify a specific 
protein in a sample. These antibodies cannot be synthesized in a laboratory and 
must be developed within an animal by employing the animal’s natural immune 
response. Peptide antigens can be injected in a rabbit to elicit antibody 
production. It can take months to develop a sufficent amount of specific antibody 
in the rabbit blood. The antibody must be tested over time to determine its 
amount and specificity. The antibody of interest in this study, rabbit antibody 
pY26, identifies phosphorylated troponin I (TnI) at the Tyrosine-26 (Tyr-26) amino 
acid residue. The antibody was tested by using four known recombinant purified 
samples: human phosphorylated TnI, human non-phosphorylated TnI, rat 
phosphorylated TnI, and rat non-phosphorylated TnI. The antibody was tested at 
five different time intervals: Pre-bleed, and bleeds 1-4. Following injection, the 
antibody should be observed on the phosphorylated samples and not observed 
on the non-phosphorylated samples. As time progressed, more antibody was 
present in serum (binding to phosphorylated TnI increased) and the antibody 
became more specific (binding to phosphorylated TnI more then non-
phosphorylation TnI). As each subsequent test bleed was used on the samples, 
the specificity and intensity of the antibody increased. Further work was done on 
the antibody in terms of determining what concentration at which it was most 
specific. Serum dilution of 1:60,000 generated the most specific results. With an 
effective antibody that identifies phosphorylated TnI Tyr-26, unknown samples 
can be compared for their pY26 phosphorylation levels. Trends of 
phosphorylation of TnI Y26 between failing and normal heart tissue can be 
established and ultimately treatments can be created depending on the effect of 
the phosphorylation.  
-The rabbit antibody TnI pY26 demonstrated increased affinity and 
specificity over time. 
 
-When applying on protein samples, the pY26 antibody is most specific 
when used at a 1:60,000 serum. 
 
-With a specific antibody and a known concentration that produces clear 
images, we can now use the antibody to monitor pY26 phosphorylation 
levels on many samples. Trends between physiological conditions and the 
pY26 phosphorylation can be better understood and established.  
The Progression of Antibody Specificity Over Time 
Conclusions 
Application 
Phosphorylation Regulation of Cardiac Contraction 
-Phosphorylation is a common post-translational modification that can 
modulate the function of the heart 
-Phosphorylation(s) present on  the inhibitory subunit of troponin (TnI) 
are an important mechanism to modulate cardiac contraction 
-Cardiac TnI is phosphorylated at Tyr-26 (pY26) with unclear results  
 
Western Blot 
-Western blot is a powerful technique involving the use of antibodies 
binding to specific proteins in a sample 
-The quantity of a certain protein and/or specific phosphorylation is 
determined by antibody binding 
 
Antibody Development 
-Injected rabbit 4 times: once every 2 weeks. Collected blood (serum) 
every 2 weeks for analysis 
-TnI amino acid sequence: N- …RRRSSANYRAYATEPHAKKK… -C 
 
-Phosphorylated amino acid sequence:        N[pY]RAYATEPH 
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Conclusion: There was no reactivity against TnI before injection. After 
injections, intensity and specificity against TnI pY≠26 increased over 
time 
 
Determining the Antibody Concentration that 
Results in Best Specificity 
(A) Bleed 2 
1:1,000 
concentration  
(B) Bleed 2 
1:30,000  
concentration 
(C) Bleed 2 
1:60,000  
concentration 
Western blot of 
purified TnI. Purified 
recombinant TnI 
samples from E. coli 
expression were 
subjected to Westen 
blot with (A) pre-
serum (before rabbit 
injections), (B) Bleed 
2 (serum obtained 
after 2 injections), 
(C) Bleed 3 (serum 
obtained after 3 
injections), (D) Bleed 
4 (serum obtained 
after 4 injections) 
 
A 
-Purify out phospho-specific from non-phospho for 
Bleeds 3 and 4 by affinity purification / affinity 
depletion to generate the final antibody 
Future Directions 
B
io
re
d 
m
ar
ke
r 
M
ou
se
 P
ho
sp
ho
 
H
um
an
 P
ho
sp
ho
 
H
um
an
 N
on
-P
ho
sp
ho
 
M
ou
se
 N
on
-P
ho
sp
ho
 
R
at
 V
en
tri
cu
la
r T
is
su
e 
B
io
re
d 
m
ar
ke
r 
B C D 
H
cT
nI
 w
t 
H
cT
nI
 w
t  
H
cT
nI
 S
23
/2
4D
 
H
cT
nI
 S
23
/2
4D
  
H
cT
nI
 w
t 
H
cT
nI
 w
t  
H
cT
nI
 S
23
/2
4D
 
H
cT
nI
 S
23
/2
4D
  
H
cT
nI
 w
t 
H
cT
nI
 w
t  
H
cT
nI
 S
23
/2
4D
 
H
cT
nI
 S
23
/2
4D
 
H
cT
nI
 w
t 
M
ou
se
 P
ho
sp
ho
 
H
um
an
 P
ho
sp
ho
 
H
um
an
 N
on
-P
ho
sp
ho
 
M
ou
se
 N
on
-P
ho
sp
ho
 
R
at
 V
en
tri
cu
la
r T
is
su
e 
B
io
re
d 
m
ar
ke
r 
Rabbit injected every 
two weeks for 10 
weeks 
Pre-bleed, Bleeds 1-4 
Progression of each 
successive serum tested by 
Western against TnI 
containing pY26 
Western blot of Time 
Lapse Kinase Assay. 
(A) Wild type or S23/24D 
TnI, without (-) or with 
(+) a tyrosine kinase 
activtor were incubated 
with Src and the reaction 
stopped at varied time 
points. Resultant 
samples were subjected 
to Western with anti-pTnI 
Y26 Bleed 2 at 1:60,000. 
(B) Quantification of 
pTnI Y26 
phosphorylation. 
37 kD 37 kD 
37 kD 
25 kD 
25 kD 
8 hr (I) 24 hr (J) 48 hr 
Western blot of purified 
TnI. Purified 
recombinant TnI 
samples, fluorescently 
stained after being 
treated with varied 
concentrations of serum. 
(A) Bleed 2 used at a 
1:1000 concentration, 
(B) Bleed 2 used at a 
1:30,000 concentration, 
(C) Bleed 2 used at a 
1:60,000 concentration. 
Conclusion: The pY26 antibody Bleed 2 serum was most specific for 
TnI Y26 phosphorylation when used at a 1:60,000 concentration. 
 
Activator + - 
(A) 
Conclusion: pTnI Y26 phosphorylation increased over time, and both the 
tyrosine kinase activator and S23/24D further increase this phosphorylation. 
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